GlassScriptPhysician profile
Judith R Buchanan
NPI 1760643381
$298.13
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Neuromuscular Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $34.05.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $95.52 | 2019 | |
| Alexion Pharmaceuticals, INC. | $39.54 | 2019 | |
| Novartis Pharmaceuticals Corporation | $33.10 | 2019 | |
| Sunovion Pharmaceuticals INC. | $23.04 | 2020 | |
| Genentech USA, INC. | $22.43 | 2019 | |
| Emd Serono, INC. | $20.87 | 2019 | |
| Biomarin Pharmaceutical INC. | $19.37 | 2019 | |
| Amgen INC. | $16.91 | 2019 | |
| Tanabe Pharma America, INC. | $16.34 | 2019 | |
| Allergan, INC. | $11.01 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Buchanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.